Product Details
| Product Name: Idarubicin | CAS No.: 58957-92-9 |
| Min. Order: 1kg | Purity: 0.99 |
| Supply Ability: 1000kg | Release date: 2025/11/04 |
Idarubicin - Product Introduction
Definition: Idarubicin is an anthracycline antibiotic and chemotherapeutic agent, derived from daunorubicin. It is used primarily for the treatment of various cancers, particularly hematological malignancies like leukemia.
Functions:
· Intercalates into DNA, inhibiting DNA and RNA synthesis, leading to cell death.
· Induces apoptosis in cancer cells by disrupting cellular replication and causing DNA damage.
· Known for its potent cytotoxic effects, especially against rapidly dividing cancer cells.
Applications:
· Pharmaceutical Industry: Used in injectable formulations for the treatment of acute myelogenous leukemia (AML), acute lymphocytic leukemia (ALL), and other hematological cancers.
· Healthcare: Administered in chemotherapy regimens for leukemia and other cancers, often in combination with other anticancer drugs to enhance efficacy.
· Research: Studied for its effectiveness in combination therapies and its potential to treat resistant cancer strains.
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1kg |
VIP2Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-04-15 | |
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-11 | ||
| $1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-07-01 | |
| $0.00/1Kg |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-04-30 | |
| $1.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2019-12-30 |
China